RESTRICTED B*44 PEPTIDES INTENDED FOR USE IN CANCER IMMUNOTHERAPY AND ASSOCIATED METHODS

MA53641AUndetermined Publication Date: 2021-07-28IMMATICS BIOTECHNOLOGIES GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA53641
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-09-17
Filing Date
2019-09-17
Publication Date
2021-07-28
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.